Re: Letter Agreement for Stock Option Grant and Acceptance BetweenNabi Biopharmaceuticals • May 5th, 2006 • Biological products, (no disgnostic substances)
Re: Letter Agreement for Retention Program Cash Bonus and Other Awards BetweenNabi Biopharmaceuticals • May 5th, 2006 • Biological products, (no disgnostic substances)
Re: Restricted Stock Agreement Between Nabi Biopharmaceuticals and «Employee»Nabi Biopharmaceuticals • May 5th, 2006 • Biological products, (no disgnostic substances)
FRESENIUS BIOTECH GmbH AND NABI BIOPHARMACEUTICALS AGREEMENT TO DEVELOP, SUPPLY AND MARKET ATG – FRESENIUS NORTH AMERICA March 30, 2006Nabi Biopharmaceuticals • May 5th, 2006 • Biological products, (no disgnostic substances) • New York
This AGREEMENT TO DEVELOP, SUPPLY AND MARKET ATG – FRESENIUS NORTH AMERICA is made as of the 30th day of March 2006, by and between FRESENIUS BIOTECH GmbH, a company organized under the laws of the Federal Republic of Germany having a principal place of business at Else-Kröner-Straße 1, 61352 Bad Homburg, Germany, hereinafter referred to as “FRESENIUS” and NABI BIOPHARMACEUTICALS, a corporation organized under the laws of Delaware having a principal place of business at 5800 Park of Commerce Blvd. N.W., Boca Raton, Florida 33487 USA, hereinafter referred to as “NABI”.
